Teladoc Health (NYSE:TDOC) Shares Gap Up – Here’s Why

Shares of Teladoc Health, Inc. (NYSE:TDOC) gapped up prior to trading on Monday . The stock had previously closed at $12.95, but opened at $13.57. Teladoc Health shares last traded at $13.67, with a volume of 4,377,657 shares.

Analysts Set New Price Targets

TDOC has been the subject of a number of research reports. Bank of America increased their price target on shares of Teladoc Health from $10.50 to $11.50 and gave the stock a “neutral” rating in a research note on Thursday, February 6th. The Goldman Sachs Group initiated coverage on shares of Teladoc Health in a research note on Friday, November 15th. They issued a “buy” rating and a $14.00 price target for the company. Oppenheimer decreased their price target on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research note on Friday, January 24th. Royal Bank of Canada upped their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Finally, Barclays upped their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Fourteen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $11.97.

Teladoc Health Price Performance

The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The firm’s 50-day simple moving average is $10.13 and its 200-day simple moving average is $9.20.

Insider Transactions at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total transaction of $28,500.77. Following the transaction, the insider now owns 2,890 shares in the company, valued at approximately $34,477.70. This represents a 45.25 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.95% of the company’s stock.

Institutional Trading of Teladoc Health

Hedge funds and other institutional investors have recently made changes to their positions in the business. Versant Capital Management Inc lifted its stake in shares of Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after buying an additional 2,441 shares in the last quarter. Whipplewood Advisors LLC acquired a new stake in Teladoc Health during the fourth quarter worth about $29,000. Lindbrook Capital LLC increased its position in Teladoc Health by 78.9% during the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock worth $33,000 after purchasing an additional 1,612 shares during the last quarter. Blue Trust Inc. increased its position in Teladoc Health by 84.5% during the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock worth $40,000 after purchasing an additional 1,854 shares during the last quarter. Finally, Generali Investments Management Co LLC acquired a new stake in Teladoc Health during the fourth quarter worth about $64,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.